JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.04B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.31B |
| 3 |
Apple
AAPL
|
+$746M |
| 4 |
Trane Technologies
TT
|
+$676M |
| 5 |
AABA
Altaba Inc
AABA
|
+$658M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.16B |
| 2 |
Honeywell
HON
|
+$701M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$667M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$656M |
| 5 |
General Motors
GM
|
+$586M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.9% |
| 2 | Financials | 14.86% |
| 3 | Technology | 11.73% |
| 4 | Healthcare | 9.66% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FBM
4601
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $3K | ﹤0.01% |
255
-8,097
| -97% | -$121K |
2017 Q1
1 quarter
|
|
|
YIN
4602
DELISTED
Yintech Investment Holdings Limited American Depositary Shares
YIN
| $3K | ﹤0.01% |
339
-752
| -69% | -$10.2K |
2016 Q3
3 quarters
|
|
|
TOO
4603
DELISTED
Teekay Offshore Partners L.P.
TOO
| $3K | ﹤0.01% |
1,000
-827,798
| -100% | -$3.3M |
2013 Q2
16 quarters
|
|
|
SDLP
4604
DELISTED
SEADRILL PARTNERS LLC
SDLP
| $3K | ﹤0.01% |
+100
| New | +$3.17K |
2017 Q2
0 quarters
|
|
|
MACK
4605
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $3K | ﹤0.01% |
364
-28,408
| -99% | -$580K |
2013 Q2
16 quarters
|
|
|
REXX
4606
DELISTED
Rex Energy Corporation
REXX
| $3K | ﹤0.01% |
1,200
| – | – |
2014 Q4
10 quarters
|
|
|
CHA
4607
DELISTED
China Telecom Corporation, LTD
CHA
| $3K | ﹤0.01% |
59
-403
| -87% | -$19.8K |
2014 Q4
10 quarters
|
|
4608
Ambarella
AMBA
$3.03B
| $2K | ﹤0.01% |
48
-88,438
| -100% | -$4.9M |
2015 Q4
6 quarters
|
|
4609
Capricor Therapeutics
CAPR
$520M
| $2K | ﹤0.01% |
+200
| New | +$3.66K |
2017 Q2
0 quarters
|
|
|
MBAI
4610
MBody AI Ltd. Ordinary Share
MBAI
$50.3M
| $2K | ﹤0.01% |
1
| – | – |
2015 Q4
6 quarters
|
|
4611
iShares CMBS ETF
CMBS
$459M
| $2K | ﹤0.01% |
32
-381
| -92% | -$19.6K |
2017 Q1
1 quarter
|
|
4612
Crawford & Co Class B
CRD.B
$573M
| $2K | ﹤0.01% |
270
-31,276
| -99% | -$304K |
2016 Q2
4 quarters
|
|
4613
CareTrust REIT
CTRE
$8.58B
| $2K | ﹤0.01% |
126
-185,709
| -100% | -$3.36M |
2016 Q1
5 quarters
|
|
|
DQ
4614
Daqo New Energy
DQ
$744M
| $2K | ﹤0.01% |
+490
| New | +$1.99K |
2017 Q2
0 quarters
|
|
4615
iShares MSCI Chile ETF
ECH
$929M
| $2K | ﹤0.01% |
54
-31,587
| -100% | -$1.37M |
2017 Q1
1 quarter
|
|
4616
Gaia
GAIA
$35.3M
| $2K | ﹤0.01% |
145
-4,538
| -97% | -$50.1K |
2016 Q4
2 quarters
|
|
4617
Gogo Inc
GOGO
$286M
| $2K | ﹤0.01% |
175
-237,460
| -100% | -$2.89M |
2016 Q3
3 quarters
|
|
|
GRX
4618
Gabelli Healthcare & Wellness Trust
GRX
$136M
| $2K | ﹤0.01% |
225
| – | – |
2015 Q4
6 quarters
|
|
|
EUHY
4619
iShares Euro High Yield Corporate Bond USD Hedged ETF
EUHY
$249M
| $2K | ﹤0.01% |
35
| – | – |
2014 Q4
10 quarters
|
|
|
KWY
4620
Kingsway Corp
KWY
$273M
| $2K | ﹤0.01% |
+300
| New | +$1.79K |
2017 Q2
0 quarters
|
|
4621
Standard BioTools
LAB
$292M
| $2K | ﹤0.01% |
440
-18,445
| -98% | -$87.5K |
2016 Q4
2 quarters
|
|
4622
Cohen & Steers Duration Preferred & Income Fund
LDP
$565M
| $2K | ﹤0.01% |
+69
| New | +$1.8K |
2017 Q2
0 quarters
|
|
|
MBCN
4623
DELISTED
Middlefield Banc Corp
MBCN
| $2K | ﹤0.01% |
+82
| New | +$2.03K |
2017 Q2
0 quarters
|
|
|
PVBC
4624
DELISTED
Provident Bancorp
PVBC
| $2K | ﹤0.01% |
198
-5,659
| -97% | -$59.5K |
2016 Q4
2 quarters
|
|
4625
Sonoma Pharmaceuticals
SNOA
$5.94M
| $2K | ﹤0.01% |
+2
| New | +$2.47K |
2017 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2017 Portfolio in Review
As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
- JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
- JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
- JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
- JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
- JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
- JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.